Bristol-Myers completes acquisition of Amylin

Bristol-Myers Squibb Co. (NYSE:BMY) completed its acquisition of Amylin Pharmaceuticals Inc. (San Diego, Calif.) for $31 per share. The $7 billion deal includes $5.3 billion for Amylin stock and $1.7 ...